AQUESTIVE THERAPEUTICS INC. - COMMON STOCK
4.5600
22-11月-24 16:44:58
15 分の遅延
株式
+0.0500
+1.11%
本日の幅
4.3900 - 4.6500
ISIN
N/A
ソース
NASDAQ
-
Aquestive Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
01 11 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Licenses Sympazan® (clobazam) Oral Film to Assertio Holdings, Inc.
27 10 2022 09:05:24 提供 Nasdaq GlobeNewswire
-
24 10 2022 08:00:00 提供 Nasdaq GlobeNewswire
-
19 10 2022 08:00:02 提供 Nasdaq GlobeNewswire
-
11 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
28 9 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
27 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
12 9 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Two Investor Conferences in September
31 8 2022 16:02:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Receives FDA Tentative Approval for Libervant™ (diazepam) Buccal Film
31 8 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Strengthens Team to Align with Strategic Focus on Allergy Space
10 8 2022 16:50:35 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
02 8 2022 16:02:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in Wedbush PacGrow Healthcare Conference
26 7 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
20 7 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
11 7 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
15 6 2022 16:22:33 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces Closing of $8.5 Million Registered Direct Offering
08 6 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics to Participate in JMP Securities Life Sciences Conference
07 6 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
06 6 2022 08:30:00 提供 Nasdaq GlobeNewswire